Efficacy of the Molded Carbon Sorbent VNIITU-1 Used in Obstetric Practice

Objective: to develop a technology for obtaining the molded sorbent VNIITU1, to study its physicochemical and biomedical properties, and to evaluate its efficacy in preventing and treating pyoinflammatory complications in obstetrics.

Materials and methods. The molded sorbent VNIITU-1 was designed from the carbon porous material based on nanodispersed carbon by mixing with a vehicle, extruding the mixture, drying the extrudate in an inert atmosphere, thermally treating and activating by steam, followed by washing with distilled water and drying (TU 9398043710698342013). The molded sorbent VNIITU-1 is apyrogenic and nontoxic (Toxicity Study Conclusion No. 1998.013.P dated 14.08.2013; Engineering Testing Assessment No. 12.404 ORTI/2013 dated 26.08.2013), it is destined for single administration, sterile, placed in a removable thread capron mesh container, and used to treat and prevent pyoseptic complications in puerperas at risk for infection, such as acute nonspecific postpartum endometritis. A total of 52 puerperas were examined and treated. They had been divided into 2 groups: a study group (n=37) and a comparison group (n=15). In the study group, the hemosorbent VNIITU1 as a porous carbon applicator was postpartum inserted into the uterine cavity, by concurrently performing traditional antibiotic therapy to prevent infectious complications. The comparison group received only traditional antibiotic therapy. The uterine cavity aspirate was examined for IL1β and IL6 levels, its microbial profile, and microbial growth patterns in culture media. The data were processed using a package of applied STATISTICA6.1 programs and standard mathematical tables in Microsoft Excel. Descriptive and variation statistical methods were applied. The data were presented as Me [low quartilehigh quartile (LQHQ)]; two pre and posttreatment dependent variables were compared using the Wilcoxon and Mann-Whitney tests.

Results. The molded carbon sorbent VNIITU1 was found to have pronounced antibacterial activity against S.aureus, P.aeroginosa, K.pneumonia, E.coli and S.agalactiae. Examination of lavages from the surface of the sorbent after its removal from the uterine cavity, by using a transmission electron microscope, revealed castoff epithelial cells, leukocytes, macrophages, and microorganisms, which determines the capacity of the sorbent to eliminate not only soluble toxins, but also microorganisms and disintegrating cell elements.

Conclusion. The proposed procedure to  postpartum endometritis in puer peras at risk for infection via insertion of the porous carbon applicator VNIITU1 into the uterine cavity is more effective than the traditional approach and it can improve treatment results, by completely eliminating pathogens from the uterus and by reducing the level of local proinflammatory cytokines.

1. Ailamazyan E.K., Kulakov V.I., Radzinsky V.E., Savelyeva G.M. Akusherstvo: Natsionalnoe Rukovodsnvo. [Obstetrics: National Leadership]. Мoscow: GEOTARMedia; 2009: 1218. [In Russ.]

2. Gursu M., Aydin Z., Pehlivanoglu F., Ozturk S., Karadag S., Uzun S., Tatli E., Kazancioglu R. Citrobacter peritonitis: two cases and review of the literature. Perit. Dial. Int. 2011; 31 (4): 409—411. http://dx.doi.org/10.3747/pdi.2010.00114. PMID: 21799055

3. Zhestkov A.V., Shlyapnikov M.E., Reshetnikova V.P., Arutyunyan K.N. Antibakterialnaya terapiya poslerodovogo endometrita. [Antibiotic therapy of postpartum endometritis]. Uralsky Meditsinsky Zhurnal. 2007; 2: 43—49. [In Russ.]

4. Kulakov V.I., Gurtovoi B.L., Ankirskaya A.S., Antonov A.G. Aktualnye problemy antimikrobnoi terapii i profilaktiki infektsii v akusherstve, ginekologii i neonatologii. [Actual problems of antimicrobial therapy and prophylaxis of infections in obstetrics, gynecology and neonatol ogy]. Akusherstvo i Ginekologiya. 2004; 1: 3—6. [In Russ.]

5. Hopkins L., Smaill F. Antibiotic prophylaxis regimens and drugs for cesarean section. Cochrane Database Syst. Rev. 2007; 2: CD001136. PMID: 10796247

6. Samsonov K.V. Sravnitelnaya effektivnost sorbtsii bakterii i bakterialnykh toksinov uglerodnymi i uglerodmineralnymi sorbentami. [The comparative effectiveness of bacteria and bacterial toxins sorption with carbonic and carbonmineral sorbents]. Byulleten Fiziologii i Patologii Dykhaniya. 2008; 29: 48—50. [In Russ.]

7. Belik E.V., Brykalov A.V., Bostanova F.A., Gryadskikh D.A., Golovkina E.M. Fabrication and study of biologically active organosilica polymer composites used for application sorption. Fibre Chemistry. 2008; 40 (5): 445—446. http://dx.doi.org/10.1007/s1069200990807

8. Kovalenko G.A., Semikolenov V.A., Kuznetsova E.V., Plaksin G.V., Rudina N.A. Uglerodnye materialy kak adsorbenty dlya biologicheski aktivnykh veshchestv i bakterialnykh kletok. [Carbon materials as adsorbents for biologically active substances and bacterial cells]. Kolloidnyi Zhurnal. 1999; 61 (6): 787—795. [In Russ.]

9. Luzyanina L.S., Pyanova L.G., Surovikin V.F., Dolgikh T.I. Sposob obrabotki uglerodnogo mezoporistogo gemosorbenta. Patent RF na izobretenie № 2362733. [A method of processing carbon mesoporous hemosorbent. RF patent for invention № 2362733]. [In Russ.]

10. Surovikin V.F., Luzyanina L.S., Pyanova L.G., Surovikin Yu.V. Uglerodnyi mezoporistyi gemosorbent. Patent RF na izobretenie № 2331581 [Mesoporous carbon hemosorbent. RF patent for invention № 2331581]. [In Russ.]

11. Baklanova O.N., Plaksin G.V., Duplyakin V.K. Blochnye uglerodnye izdeliya sotovoi struktury: osobennosti tekhnologii polucheniya, oblasti primeneniya. [Block carbon honeycomb products: features technology for proceeding, the application]. Rossiisky Khimichesky Zhurnal. 2007; 51 (4): 119125. [In Russ.]

12. Dolgikh T.I., Pyanova L.G., Baklanova O.N., Dolgikh V.T., Likholobov V.A., Barinov S.V., Sedanova A.V., Barakina O.V. Antibakterialnaya aktivnost granulirovannykh uglerodnykh sorbentov applikatsionnogo naznacheniya. [Antibacterial activity of granular carbon sorbents for application]. Sibirsky Meditsinsky Zhurnal (Irkutsk). 2013; 122 (7): 77—82. [In Russ.]

13. Titov V.N. Rol makrofagov v stanovlenii vospaleniya, deistvie interleikina-1, interleikina6 i aktivnosti gipotalamogipofizarnoi sistemy (obzor literatury). [The role of macrophages in inflammation development, effects of interleukin-1, interleukin6, and hypothalamohypophyseal system activity (a literature review)]. Klinicheskaya. Laboratornaya Diagnostika. 2003; 12: 3—10. PMID: 14971316. [In Russ.]

14. Belokrinitskaya T.E., Akhmetova E.S., Murikova E.V. Rol tsitokinov v vozniknovenii anomalnykh matochnykh krovotechenii pri prolifera tivnykh zabolevaniyakh endometriya.[Role of cytokines in the devel opment of pathological intrauterine hemorrhage in proliferative diseases of endometrium]. Sibirskoe Meditsinskoe Obozrenie. 2008; 2 (50): 43—45. [In Russ.]